Helicobacter pylori noninvasive testing market Growth, Share, Trends and
forecast (2019 - 2030)
The global helicobacter pylori (H. pylori) non-invasive testing market is driven by the high prevalence
rates of Helicobacter pylori globally, the noninvasive nature of these tests, which also tend to be user-
friendly. The global helicobacter pylori (H. pylori) non-invasive testing market was dominated by North
America due to factors such as the rapid technological advancements in the field and the rising
awareness about the non-invasive testing options, of Helicobacter pylori (h. pylori) non-invasive testing.
Australian scientists Barry Marshall and Robin Warren had identified Helicobacter pylori (bacteria
generally found in the stomach) in 1982 and also found that Helicobacter pylori were present in a
person with chronic gastritis and gastric ulcers, these conditions were not previously believed to have a
microbial cause. The leading players in the global helicobacter pylori (H. pylori) non-invasive testing
market are DiaSorin S.p.A., Exalenz Bioscience Ltd., Thermo Fisher Scientific, Alere, Certest Biotec S.L
Meridian Bioscience, Inc., Sekisui Diagnostics, Biomerica, Inc, CorisBioconcept SPRL, and Shenzhen
Zhonghe Headway Bio-Sci & Tech Co., Ltd. among others.
Get Free Sample Report Copy Of Global Helicobacter Pylori (H. pylori) Non-invasive Testing
Market @ https://www.marketindustryreports.com/pdf/73
Low Diagnosis Rates
Although more than half the world’s population is infected by the helicobacter pylori infection the
diagnosis rates remain low globally. One of the main reasons for low diagnosis rates is the fact that
this infection is largely asymptomatic. Hence in spite of having high prevalence rates, since no
specific symptoms are displayed, the patient has no complaints and does not go to get diagnosed,
resulting in low diagnosis rate. Low diagnosis rates coupled with stringent regulatory scenario is
expected to impede the growth of the helicobacter pylori (H. pylori) non-invasive testing market.
Swift Growth in the Asia Pacific Region
Asia Pacific is estimated to witness the highest CAGR during the forecast period. Increasing
population that results in overcrowding, poor personal hygiene, dearth of adequate potable water
supply, inadequate sanitation and poor food hygiene, are some of the pivotal factors fuelling the
growth of the helicobacter pylori noninvasive testing market in this region. North America is expected
to hold a substantial market share, followed by Europe in the forecast period. Rising awareness
amongst the patient population and availability of noninvasive testing options is expected to fuel the
growth of the market in these regions.
Major Players in the Helicobacter Pylori (H. pylori) Non-invasive Testing Market
The prominent players in the global helicobacter pylori (H. pylori) non-invasive testing market are
Meridian Bioscience, Inc., DiaSorin S.p.A., Exalenz Bioscience Ltd., Thermo Fisher Scientific, Alere,
Certest Biotec S.L, Sekisui Diagnostics, Biomerica, Inc, CorisBioconcept SPRL, and Shenzhen
Zhonghe Headway Bio-Sci & Tech Co., Ltd. Among othe